Pieris Pharmaceuticals Is A Clinical Stagebiotechnology Company Based In Bostonmassachusettsthecompany Specializes In Developing Innovativetreatments For Respiratory Diseases And Cancer Using Its Proprietary Anticalinaplatformfollowing Its Merger With Palvella Therapeutics In December 2024Pieris Pharmaceuticals Has Expanded Its Focus To Includetherapies For Seriousraregenetic Skin Diseases Thecompany Is Engaged In Thediscovery And Development Of Anticalin Based Drugswhich Area Uniqueclass Of Therapeuticsits Pipelinefeatures Several Drug Candidatesincluding An Inhaled Il 4Riantagonist For Respiratory Conditions And Locally Activated Bispecifics For Immuno Oncologypieris Collaborates With Major Pharmaceutical Companiesincluding Genentech And Boston Pharmaceuticalsto Advanceits Drug Development Efforts
No conferences found for this company.
| Company Name | Palvella Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
